scholarly journals Should Cough Syrups be Used In children?

2020 ◽  
Vol 7 (2) ◽  
pp. 56-59
Author(s):  
Dr. Rimjhim Sahu ◽  
Dr. Vijay Thawani
Keyword(s):  
Drug Administration ◽  
Respiratory Infections ◽  
Food And Drug Administration ◽  
Over The Counter ◽  
Runny Nose ◽  
Upper Respiratory Infections ◽  
Temporary Relief ◽  
Upper Respiratory ◽  
Cough Suppressant

Many over the counter available cough and cold medications contain combination  of a decongestant, cough suppressant, antihistamine, expectorant, or antipyretic, which are irrational. Parents administer these medications to children for giving temporary relief from the discomfort caused by the of upper respiratory infections  such as runny nose, congestion, cough, and fever. As per the recommendation of US Food and Drug Administration, children under the age of two should never be given these preparations. Most of the labels of products mention that cough and cold preparations should not be given to children under the age of four. Yet the practice continues.

scholarly journals Physician’s prescription pattern in young infants with upper respiratory infections/cough and cold in emergency department

2019 ◽  
Vol 36 (2) ◽  
Author(s):  
Caner Turan ◽  
Ali Yurtseven ◽  
Eylem Ulas Saz
Keyword(s):  
Emergency Department ◽  
Respiratory Infections ◽  
Pediatric Emergency ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Over The Counter ◽  
Prescription Pattern ◽  
Upper Respiratory Infections ◽  
Young Infants ◽  
Upper Respiratory

Objective: Despite the national/international warnings and little evidence as to whether over-the-counter cough and cold medications (OTC-CCM) are effective, physicians frequently overprescribe, parents overuse these drugs and antibiotics for URTIs in young child. This study aimed to determine the prescription pattern of over-the-counter cough and cold medications (OTC-CCM) in children less than two years. Methods: This was a cross-sectional study in which we collected physicians prescriptions in young infants less than two years of age with ARI (acute respiratory infections) who visited pediatric emergency department (ED) between September 2017-April 2018 and received prescription with OTC-CCM enrolled. Infants who did not receive OTC-CCM were excluded. Results: During the study period 2476 infants presented to the ED and 1452 (58.6%) had prescription with OTC-CCM. Analyzing the prescription details revealed that 63.8% was with decongestants, 53.5% antitussive and 52.7% antibiotics. One third of the prescriptions with these medications were written by pediatricians (p=0.001). Physicians had tendency to prescribe antibiotic if the infants had fever higher than 38°C (p=0.02). Conclusion: We observed that international and national warnings did not show a considerable impact on the prescription pattern. Despite international and national reports, physicians frequently prescribe OTC-CCM in infants. doi: https://doi.org/10.12669/pjms.36.2.1240 How to cite this:Turan C, Yurtseven A, Saz EU. Physician’s prescription pattern in young infants with upper respiratory infections/cough and cold in emergency department. Pak J Med Sci. 2020;36(2):---------. doi: https://doi.org/10.12669/pjms.36.2.1240 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Do over-the-counter remedies relieve cough in acute upper respiratory infections?

2016 ◽  
Vol 19 (9) ◽  
pp. 1-2
Author(s):  
Sandy Robertson ◽  
Mark Robinson ◽  
Amanda Schultz ◽  
Rachel Villella
Keyword(s):  
Respiratory Infections ◽  
Over The Counter ◽  
Upper Respiratory Infections ◽  
Upper Respiratory

scholarly journals A 12-month follow-up of an influenza vaccination campaign based on voluntary adherence: report on upper-respiratory symptoms among volunteers and non-volunteers

2001 ◽  
Vol 119 (4) ◽  
pp. 142-145 ◽  
Author(s):  
Páris Ali Ramadan ◽  
Francisco Barreto de Araújo ◽  
Mario Ferreira Junior
Keyword(s):  
Respiratory Symptoms ◽  
Respiratory Infections ◽  
Vaccination Campaign ◽  
Influenza Like Illness ◽  
Upper Respiratory Infections ◽  
Medical Consultations ◽  
History Of ◽  
Upper Respiratory ◽  
Upper Respiratory Symptoms

CONTEXT: Routine immunization of groups at high risk for influenza has been progressively implemented as a matter of Brazilian public health policy. Although the benefits of the vaccination for healthy young adults are still controversial, it has been offered yearly to hundreds of thousands of Brazilian workers, generally as part of wellness initiatives in the workplace. OBJECTIVE: To study the characteristics of subjects that accepted or refused to be vaccinated against influenza and to report on respiratory symptoms in both groups, one year after the campaign date. DESIGN: A prospective observational study. SETTING: Workers at a subsidiary of an international bank in São Paulo, Brazil. PARTICIPANTS: 124 persons that did not accept and 145 that voluntarily accepted the vaccine completed 12 months of follow-up. MAIN MEASUREMENTS: Data concerning gender, age, tobacco use, and any history of chronic respiratory illness such as asthma, bronchitis, rhinitis, and repetitive upper-respiratory infections, were recorded at the time of vaccination. After that, workers were asked monthly by questionnaire or telephone about respiratory symptoms, days of work lost and medical consultations. RESULTS: The results showed statistically significant differences regarding age (P = 0.004) with the vaccinated group (V) being younger than the non-vaccinated (NV) one, and with reference to previous repetitive upper-respiratory infections being higher among the V group (P < 0.0001). During the follow-up, the V group reported more occurrences of upper respiratory symptoms (P < 0.0001), due to both non-influenza (P < 0.0001) and influenza-like illness (P = 0.045). Differences were also found between V and NV groups concerning days off work and number of medical consultations due to upper-respiratory symptoms and non-influenza illness. Gender and history of repetitive upper-respiratory infections were the best predictors of influenza-like illness-related events. CONCLUSIONS: The making of previous reference to repetitive upper-respiratory infections was a major difference between those who accepted or rejected the vaccine. The vaccination itself was not sufficient to reduce the number of occurrences of respiratory symptoms and related absenteeism to levels similar to those found among non-vaccinated people.

scholarly journals Recent Epidemiological Status of Feline Upper Respiratory Infections in Japan.

2000 ◽  
Vol 62 (7) ◽  
pp. 801-803 ◽  
Author(s):  
Masami MOCHIZUKI ◽  
Kazuo KAWAKAMI ◽  
Michiru HASHIMOTO ◽  
Takuo ISHIDA
Keyword(s):  
Respiratory Infections ◽  
Upper Respiratory Infections ◽  
Upper Respiratory
Sign in / Sign up

Export Citation Format

Share Document